Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency

American Journal of Hypertension

Volumn 22, Issue 9, 2009, Pages 964-970

  Kurra, Venla ^a   Eräranta, Arttu ^a   Jolma, Pasi ^a,b   Vehmas, Tuija I ^a   Riutta, Asko ^a   Moilanen, Eeva ^a   Tahvanainen, Anna ^a   Kalliovalkama, Jarkko ^c   Niemelä, Onni ^d   Myllymäki, Juhani ^a,b   Mustonen, Jukka ^a,b   Pörsti, Ilkka ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c Coxa Hospital for Joint Replacement ^*  (Finland)

^d SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLCHOLINE; CREATININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; OXONIC ACID; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BLOOD VESSEL TONE; BODY WEIGHT; CAROTID ARTERY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULOSCLEROSIS; HEART RATE; HYPERURICEMIA; KIDNEY FAILURE; MALE; MYOGRAPHY; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; URIC ACID BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; VASODILATATION;

ANIMALS; CAROTID ARTERIES; CREATININE; DINOPROST; HYPERURICEMIA; MALE; NEPHRECTOMY; NG-NITROARGININE METHYL ESTER; OXIDATIVE STRESS; OXONIC ACID; PEROXIDES; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY; URIC ACID; VASODILATION;

EID: 69249230811     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.109     Document Type: Article

References (40)

1. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183-1190.
2. Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002; 29:1350-1355.
3. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283:2404-2410.
4. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993; 270:354-359.
5. Eräranta A, Kurra V, Tahvanainen AM, Vehmas TI, Kööbi P, Lakkisto P, Tikkanen I, Niemelä OJ, Mustonen JT, Pörsti IH. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency. J Hypertens 2008; 26:1661-1668.
6. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13:2888-2897.
7. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38:1101-1106.
8. Sánchez-Lozada LG, Tapia E, Santamaría J, Avila-Casado C, Soto V, Nepomuceno T, Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005; 67:237-247.
9. Nakagawa T, Mazzali M, Kang DH, Kanellis J, Watanabe S, Sanchez-Lozada LG, Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003; 23:2-7.
10. Sánchez-Lozada LG, Tapia E, López-Molina R, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol 2007; 292:F1238-F1244.
11. Sánchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, Nakagawa T, Franco M, Rodríguez-Iturbe B, Johnson RJ. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008; 295:F1134-F1141.
12. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67:1739-1742.
13. Vigna GB, Bolzan M, Romagnoni F, Valerio G, Vitale E, Zuliani G, Fellin R. Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation 1992; 85:2205-2211.
14. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29:635-639.
15. Patetsios P, Song M, Shutze WP, Pappas C, Rodino W, Ramirez JA, Panetta TF. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 2001; 88:188-91, A6.
16. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986; 235:747-754.
17. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 2000; 376:333-337.
18. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, Harrison DG, Fukai T. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 2002; 22:1402-1408.
19. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002; 39:135-141.
20. Jolma P, Kööbi P, Kalliovalkama J, Saha H, Fan M, Jokihaara J, Moilanen E, Tikkanen I, Pörsti I. Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure. Nephrol Dial Transplant 2003; 18:2560-2569.
21. Kööbi P, Kalliovalkama J, Jolma P, Rysä J, Ruskoaho H, Vuolteenaho O, Kähönen M, Tikkanen I, Fan M, Ylitalo P, Pörsti I. AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension 2003; 41:1364-1371.
22. Pörsti I, Fan M, Kööbi P, Jolma P, Kalliovalkama J, Vehmas TI, Helin H, Holthöfer H, Mervaala E, Nyman T, Tikkanen I. High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure. Kidney Int 2004; 66:2155-2166.
23. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998; 53:613-625.
24. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34:1951-1956.
25. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 2002; 33:1048-1052.
26. Arvola P, Wu X, Kähönen M, Mäkynen H, Riutta A, Mucha I, Solakivi T, Kainulainen H, Pörsti I. Exercise enhances vasorelaxation in experimental obesity associated hypertension. Cardiovasc Res 1999; 43:992-1002.
27. Praetorius E, Poulsen H. Enzymatic determination of uric acid; with detailed directions. Scand J Clin Lab Invest 1953; 5:273-280.
28. Alanko J, Riutta A, Holm P, Mucha I, Vapaatalo H, Metsä-Ketelä T. Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant/prooxidant properties. Free Radic Biol Med 1999; 26:193-201.
29. Dugué B, Smolander J, Westerlund T, Oksa J, Nieminen R, Moilanen E, Mikkelsson M. Acute and long-term effects of winter swimming and whole-body cryotherapy on plasma antioxidative capacity in healthy women. Scand J Clin Lab Invest 2005; 65:395-402.
30. Rossi P, Riutta A, Kuukasjärvi P, Vehmas T, Mucha I, Salenius JP. Revascularization decreases 8-isoprostaglandin F2alpha excretion in chronic lower limb ischemia. Prostaglandins Leukot Essent Fatty Acids 2004; 71:97-101.
31. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-513.
32. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82:131-185.
33. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26:269-275.
34. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest 1991; 100:176S-181S.
35. Waring WS, Webb DJ, Maxwell SR. Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 2001; 38:365-371.
36. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006; 55:3127-3132.
37. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci 2003; 105:425-430.
38. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY. Serum uric acid levels show a "J-shaped" association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004; 19:457-462.
39. Vaziri ND, Liang K, Parks JS. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. Kidney Int 2001; 59:2192-2196.
40. Mougenot N, Lesnik P, Ramirez-Gil JF, Nataf P, Diczfalusy U, Chapman MJ, Lechat P. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro. Atherosclerosis 1997; 133:183-192.